WHO Experts Review Pakistan’s mRNA Vaccine Capacity at NIH Labs
The laboratories, established with support from WHO’s mRNA Technology Transfer Programme and the Medicines Patent Pool, aim to strengthen local vaccine research and manufacturing and prepare for future pandemic threats.
ISLAMABAD, (Pakistan Point News - 19th Nov, 2026) International experts from the World Health Organization (WHO) have visited newly established messenger RNA (mRNA) vaccine laboratories at the National Institutes of Health (NIH), Islamabad.
The objective to visit these labs was to review efforts aimed at strengthening Pakistan’s capacity to develop and deliver vaccines rapidly in response to future pandemic threats.
The laboratories have been established with support from WHO’s mRNA Technology Transfer Programme and the Medicines Patent Pool (MPP), as part of international efforts to enhance local vaccine research, development and manufacturing capabilities.
The initiative is expected to strengthen Pakistan’s preparedness for emerging infectious diseases by promoting access to advanced vaccine technologies and building domestic capacity for a faster response to future public health emergencies.
内容来自 UrduPoint News,版权归原作者所有。
阅读原文 ↗